|
|||||
|
|
| 脑梗死两种治疗方案的药物经济学分析 | |
| 引用本文： | 温海波,蔡颖谦. 脑梗死两种治疗方案的药物经济学分析[J]. 中华神经医学杂志, 2006, 5(5): 529-530 |
| 作者姓名： | 温海波 蔡颖谦 |
| 作者单位： | 1. 512026,韶关,广东省粤北人民医院 2. 510282,广州,南方医科大学珠江医院神经外科 |
| 摘 要： | 目的评价应用葛根素与血塞通治疗脑梗死的疗效及成本-效果比。方法运用药物经济学成本-效果分析方法,对葛根素与血塞通治疗94例脑梗死病人的疗效及成本进行比较、分析。结果葛根素与血塞通治疗脑梗死总有效率分别为88．89％、87．76％,成本-效果比分别为 5．62、3．28。结论葛根素与血塞通均能有效治疗脑梗死,但血塞通成本-效果比优于葛根素。 |
| 关 键 词： | 脑梗死 成本-效果分析 葛根素 血塞通 |
| 文章编号： | 1671-8925（2006）05-529-002 |
| 收稿时间： | 2006-01-19 |
| 修稿时间： | 2006-01-19 |
Pharmacoeconomic analysis of 2 therapeutic schemes for cerebral infarction |
|
| WEN Hai-bo,CAI Ying-qian. Pharmacoeconomic analysis of 2 therapeutic schemes for cerebral infarction[J]. Chinese Journal of Neuromedicine, 2006, 5(5): 529-530 | |
| Authors: | WEN Hai-bo CAI Ying-qian |
| Abstract: | Objective To compare the therapeutic effects and the cost-effectiveness between puerarin and Xuesaitong in the treatment of cerebral infarction. Methods Using pharmacoeconomic cost-effectiveness analysis, puerarin was compared with Xuesaitong in the treatment of 94 patients with cerebral infarction. Results The total effective rates of puerarin and Xuesaitong were 88.89% and 87.76%, respectively, the cost-effectiveness ratios were 5.62 and 3.28, respectively. Conclusion Both of puerarin and Xuesaitong can effectively treat cerebral infarction, but the coat-effectiveness ratio of Xuesaitong is superior to that of puerarin. |
| Keywords: | Cerebral infarction Cost-effectiveness analysis Puerarin Xuesaitong |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |